ALCOX:EPA
NicOx SA
€0.29
arrow_downward
-1.03%(-0.0030) 1D
Nov 13, 5:35:02 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCOX...
Open
€0.30
High
€0.30
Low
€0.29
Mkt. cap
28.14M
Avg. vol.
134.07K
Volume
82.75K
P/E ratio
4.97
52-wk high
€0.57
52-wk low
€0.28
EPS
€0.06
Shares outstanding
99.07M
No. of employees
5
Open
€0.30
High
€0.30
Low
€0.29
Mkt. cap
28.14M
Avg. vol.
134.07K
Volume
82.75K
P/E ratio
4.97
52-wk high
€0.57
52-wk low
€0.28
EPS
€0.06
Shares outstanding
99.07M
No. of employees
5
News stories
From web sources and news partners
巴士的報
·
2 hours ago
U.S. stocks close mixed as chip sell-off deepens
Traders Union
·
6 hours ago
S&P 500 gains $1.2 trillion in a week, Peter Tuchman notes
qz.com
·
5 hours ago
How much of the S&P 500 is Nvidia? Concentration explained
FOREX.com
·
8 hours ago
S&P 500 forecast: SPX struggles for direction ahead of PPI data
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees5
Founded1996
HeadquartersValbonne, Provence-Alpes-Côte d'Azur, France
SectorHealth Care
IndustryBiotechnology
Websitenicox.com